Mark W. Schwartz
2011
In 2011, Mark W. Schwartz earned a total compensation of $568.3K as Executive Vice President and Chief Operating Officer at Galena Biopharma.
Compensation breakdown
| Bonus | $108,177 |
|---|---|
| Option Awards | $224,264 |
| Salary | $235,673 |
| Other | $213 |
| Total | $568,327 |
Schwartz received $235.7K in salary, accounting for 41% of the total pay in 2011.
Schwartz also received $108.2K in bonus, $224.3K in option awards and $213 in other compensation.
Rankings
In 2011, Mark W. Schwartz's compensation ranked 7,635th out of 10,747 executives tracked by ExecPay. In other words, Schwartz earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,635 out of 10,747 | 29th |
Division Manufacturing | 2,795 out of 3,960 | 29th |
Major group Chemicals And Allied Products | 690 out of 1,033 | 33rd |
Industry group Drugs | 485 out of 781 | 38th |
Industry Pharmaceutical Preparations | 375 out of 571 | 34th |
Source: SEC filing on April 30, 2012.
Schwartz's colleagues
We found five more compensation records of executives who worked with Mark W. Schwartz at Galena Biopharma in 2011.
2011
Mark Ahn
Galena Biopharma
Chief Executive Officer
2011
Noah Beerman
Galena Biopharma
Chief Executive Officer
2011
Anastasia Khvorova
Galena Biopharma
Chief Scientific Officer
2011
Pamela Pavco
Galena Biopharma
Vice President of Pharmaceutical Development, RXi Pharmaceuticals Corporation
2011
Kwang Lee
Galena Biopharma